Drugs causing adverse events in patients aged 45 or older: A randomised survey of Australian general practice patients

BMJ Open

Volumn 3, Issue 10, 2013, Pages

  Miller, Graeme C ^a   Valenti, Lisa ^a   Britt, Helena ^a   Bayram, Clare ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANILIDE; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE DERIVATIVE; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PENICILLIN DERIVATIVE; PROTON PUMP INHIBITOR; SALICYLIC ACID DERIVATIVE; SEROTONIN UPTAKE INHIBITOR;

ABDOMINAL PAIN; ADULT; ADVERSE DRUG REACTION; ANKLE INJURY; ANXIETY; ARTICLE; AUSTRALIA; CLINICAL FEATURE; CONSTIPATION; COUGHING; CROSS-SECTIONAL STUDY; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG HYPERSENSITIVITY; DRUG OVERDOSE; EDEMA; EPIGASTRIC PAIN; FATIGUE; FEMALE; FEVER; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; GENERAL PRACTICE; GENERAL PRACTITIONER; HEART ARRHYTHMIA; HEART PALPITATION; HEMATURIA; HEMOPTYSIS; HOSPITALIZATION; HUMAN; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; MELENA; MORBIDITY; MYALGIA; NAUSEA; NEUROLOGIC DISEASE; ORTHOSTATIC HYPOTENSION; PAIN; PEPTIC ULCER; PRESCRIPTION; PREVALENCE; RASH; SIDE EFFECT; SLEEP DISORDER; SPEECH DISORDER; TINNITUS; URTICARIA; VERTIGO; VOMITING; WEAKNESS;

EID: 84886655855     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003701     Document Type: Article

References (31)

1. Australian Government Department of Health and Ageing. Medicare Statistics-March quarter 2011, Group BC tables. Canberra: DOHA. http://www.health.gov.au/internet/main/publishing.nsf/Content/ medstat-mar11-tables-bc (accessed Sep 2011).
2. Britt HC, Harrison CM, Miller GC, et al. Prevalence and patterns of multimorbidity in Australia. Med J Aust 2008;189:72-7.
3. Caughey GE, Vitry AI, Gilbert AL, et al. Prevalence of comorbidity of chronic diseases in Australia. BMC Public Health 2008;8:221.
4. Laroche ML, Charmes JP, Nouaille Y, et al. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol 2007;63:177-86. (Pubitemid 46072104)
5. Calderon-Larranaga A, Poblador-Plou B, Gonzalez-Rubio F, et al. Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well? Br J Gen Pract 2012;62:e821-6.
6. Bourgeois FT, Shannon MW, Valim C, et al. Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf 2010;19:901-10.
7. Sarkar U, Lopez A, Maselli JH, et al. Adverse drug events in US adult ambulatory medical care. Health Serv Res 2011;46:1517-33.
8. Miller GC, Britt HC, Valenti L. Adverse drug events in general practice patients in Australia. Med J Aust 2006;184:321-4.
9. Tache SV, Sonnichsen A, Ashcroft DM. Prevalence of adverse drug events in ambulatory care: a systematic review. Ann Pharmacother 2011;45:977-89.
10. Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991;151:1825-32.
11. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997;157:1531-6. (Pubitemid 27305197)
12. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003;163:2716-24. (Pubitemid 37517412)
13. Britt H, Miller GC, Charles J, et al. General practice activity in Australia 2008-09. Canberra: Australian Institute of Health and Welfare, 2009. (AIHW Cat. No. GEP 25;) (General Practice Series No. 25). http://www.aihw.gov. au/publications/index.cfm/title/11013
14. Britt H, Miller GC, Henderson J, et al. General practice activity in Australia 2011-12. Sydney: Sydney University Press, 2012. (General practice series no. 31). http://purl.library.usyd.edu.au/sup/9781743320181
15. AIHW Australian GP Statistics and Classification Centre. SAND Method: 2009-10. SAND abstracts from the BEACH program. [serial on the Internet]. Sydney: The University of Sydney. http://nla.gov.au/nla.arc-14007 (accessed Feb 2012).
16. Driver B, Britt H, O'Toole B, et al. How representative are patients in general practice morbidity surveys? Fam Pract 1991;8:261-8.
17. Britt H, Harris M, Driver B, et al. Reasons for encounter and diagnosed health problems: convergence between doctors and patients. Fam Pract 1992;9:191-4.
18. Britt H, Miller GC, Steven ID, et al. Collecting data on potentially harmful events: a method for monitoring incidents in general practice. Fam Pract 1997;14:101-6. (Pubitemid 27179987)
19. World Health Organization Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) classification index with Defined Daily Doses (DDDs). January 2009 ed. Oslo: WHO; 2009. http://www.whocc.no/
20. Classification Committee of the World Organization of Family Doctors. ICPC-2: international classification of primary care. 2nd edn. Oxford: Oxford University Press, 1998.
21. SAS Proprietary Software Release 9.1. Cary: SAS Institute Inc, 2003.
22. Britt H, Miller GC, Charles J, et al. General practice activity in Australia 2006-07. Canberra: Australian Institute of Health and Welfare, 2008. (AIHW Cat. No. GEP 21); (General practice series no. 21). http://www.aihw.gov. au/publications/index.cfm/title/10574
23. Fischer G, Fetters MD, Munro AP, et al. Adverse events in primary care identified from a risk-management database. J Fam Pract 1997;45:40-6. (Pubitemid 27332524)
24. Moore TJ, Psaty BM, Furberg CD. Time to act on drug safety. JAMA 1998;279:1571-3. (Pubitemid 28233014)
25. Motl S, Timpe E, Eichner S. Proposal to improve MedWatch: decentralized, regional surveillance of adverse drug reactions. Am J Health Syst Pharm 2004;61:1840-2. (Pubitemid 39481368)
26. Bains N, Hunter D. Adverse reporting on adverse reactions. CMAJ 1999;160:350-1. (Pubitemid 29092560)
27. Lexchin J. Adverse drug reactions: review of the Canadian literature. Can Fam Physician 1991;37:109-18.
28. Lexchin J. Rethinking the numbers on adverse drug reactions. CMAJ 1999;160:1432. (Pubitemid 29248421)
29. World Health Organization. Medicines: safety of medicines-adverse drug reactions. Fact sheet no. 283. Geneva: WHO, http://www.who.int/mediacentre/ factsheets/fs293/en/(accessed Mar 2013).
30. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med 2003;348:1556-64. (Pubitemid 36437933)
31. Budnitz DS, Lovegrove MC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011;365:2002-12.